|
| | Publication Year | Title | Author(s) |
| 701 | 2022 | Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC. | Wu, Yi-Long; John, Thomas ; Grohe, Christian; Majem, Margarita; Goldman, Jonathan W; Kim, Sang-We; Kato, Terufumi; Laktionov, Konstantin; Vu, Huu Vinh; Wang, Zhijie; Lu, Shun; Lee, Kye Young; Akewanlop, Charuwan; Yu, Chong-Jen; de Marinis, Filippo; Bonanno, Laura; Domine, Manuel; Shepherd, Frances A; Zeng, Lingmin; Atasoy, Ajlan; Herbst, Roy S; Tsuboi, Masahiro |
| 702 | Oct-2022 | Potentiating effect of reovirus on immune checkpoint inhibition in microsatellite stable colorectal cancer. | Augustine, Titto; John, Peter; Friedman, Tyler; Jiffry, Jeeshan; Guzik, Hillary; Mannan, Rifat; Gupta, Riya; Delano, Catherine; Mariadason, John M ; Zang, Xingxing; Maitra, Radhashree; Goel, Sanjay |
| 703 | Feb-2021 | Pralatrexate in relapsed/refractory T-cell lymphoma: a retrospective multicenter study. | Bhurani, Mansi; Admojo, Lorenz; Van Der Weyden, Carrie; Twigger, Robert; Bazargan, Ali; Quach, Hang; Zimet, Allan; Coyle, Luke; Lindsay, Julian; Radeski, Dejan; Hawkes, Eliza A ; Kennedy, Glen; Irving, Ian; Gutta, Naadir; Trotman, Judith; Yeung, James; Dunlop, Lindsay; Hua, Minh; Giri, Pratyush; Yuen, Sam; Panicker, Shyam; Moreton, Susan; Khoo, Liane; Scott, Ashleigh; Kipp, David; McQuillan, Andrew; McCormack, Chris; Dickinson, Michael; Prince, Henry Miles |
| 704 | 18-Jul-2018 | Preclinical toxicological assessment of a novel monoclonal antibody targeting human platelet-derived growth factor CC (PDGF-CC) in PDGF-CChum mice. | Zeitelhofer, Manuel; Li, Hong; Adzemovic, Milena Z; Nilsson, Ingrid; Muhl, Lars; Scott, Andrew M ; Eriksson, Ulf |
| 705 | 15-Aug-2008 | Predicting clinical outcome through molecular profiling in stage III melanoma. | John, Thomas ; Black, Michael A; Toro, Tumi T; Leader, Debbie; Gedye, Craig A; Davis, Ian D; Guilford, Parry J; Cebon, Jonathan S |
| 706 | 8-Jul-2021 | Predicting primary treatment failure using interim FDG-PET scanning in Diffuse large B-cell lymphoma. | Wight, Joel C ; Wai, Shin Hnin; Shen, Edward; Lee, Sze Ting ; Berlangieri, Salvatore U ; Fancourt, Tineke ; Hawkes, Eliza A ; Hannah, Anthony; Leung, Teresa; Chong, Geoffrey |
| 707 | 1-Oct-2022 | Predictive value of chromosome 18q11.2-q12.1 loss for benefit from bevacizumab in metastatic colorectal cancer: A post hoc analysis of the randomized phase III-trial AGITG-MAX. | van Dijk, Erik; van Werkhoven, Erik; Asher, Rebecca; Mooi, Jennifer K ; Espinoza, David; van Essen, Hendrik F; van Tinteren, Harm; van Grieken, Nicole C T; Punt, Cornelis J A; Tebbutt, Niall C ; Ylstra, Bauke |
| 708 | 28-Jun-2022 | Preferential Antibody and Drug Conjugate Targeting of the ADAM10 Metalloprotease in Tumours. | Yan, Hengkang; Vail, Mary E; Hii, Linda; Guo, Nancy; McMurrick, Paul J; Oliva, Karen; Wilkins, Simon; Saha, Nayanendu; Nikolov, Dimitar B; Lee, Fook-Thean; Scott, Andrew M ; Janes, Peter W |
| 709 | 10-Apr-2015 | Pregnancy Associated Plasma Protein-A links pregnancy and melanoma progression by promoting cellular migration and invasion. | Prithviraj, Prashanth; Anaka, Matthew; McKeown, Sonja J; Permezel, Michael; Walkiewicz, Marzena; Cebon, Jonathan S ; Behren, Andreas; Jayachandran, Aparna |
| 710 | Nov-2020 | A preliminary assessment of oral monepantel's tolerability and pharmacokinetics in individuals with treatment-refractory solid tumors. | Mislang, Anna; Mollard, Richard; Tapia Rico, Gonzalo; Fairlie, Walter Douglas ; Lee, Erinna F; Harris, Tiffany J ; Aston, Roger; Brown, Michael P |
| 11 | Jun-2020 | Preliminary study highlights the potential of immune checkpoint inhibitors in sarcomatoid mesothelioma. | Brockwell, Natasha K; Alamgeer, Muhammad; Kumar, Beena; Rivalland, Gareth; John, Thomas ; Parker, Belinda S |
| 12 | 20-Nov-2014 | Prevalence and natural history of ALK positive non-small-cell lung cancer and the clinical impact of targeted therapy with ALK inhibitors. | Chia, Puey Ling ; Mitchell, Paul L R ; Dobrovic, Alexander ; John, Thomas |
| 13 | May-2021 | Prevalence of hypoxia and correlation with glycolytic metabolism and angiogenic biomarkers in metastatic colorectal carcinoma. | Lee, Sze Ting ; Muralidharan, Vijayaragavan ; Tebbutt, Niall C ; Wong, P; Fang, C; Liu, Z; Gan, Hui K ; Sachinidis, J; Pathmaraj, Kunthi ; Christophi, Christopher ; Scott, Andrew M |
| 14 | 21-May-2007 | Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules. | Lee, S T; Berlangieri, Salvatore U ; Poon, A M T; Mitchell, Paul L R ; Pathmaraj, K ; Tabone, K; Byrne, Amanda J; O'Keefe, Graeme J; Knight, Simon R ; Clarke, C Peter; Scott, Andrew M |
| 15 | Mar-2017 | Probe-Free Digital PCR Quantitative Methodology to Measure Donor-Specific Cell-Free DNA after Solid-Organ Transplantation. | Goh, Su Kah ; Muralidharan, Vijayaragavan ; Christophi, Christopher ; Do, Hongdo; Dobrovic, Alexander |
| 16 | 29-Apr-2010 | Processing and cross-presentation of individual HLA-A, -B, or -C epitopes from NY-ESO-1 or an HLA-A epitope for Melan-A differ according to the mode of antigen delivery. | Robson, Neil C; McAlpine, Tristan; Knights, Ashley J; Schnurr, Max; Shin, Amanda; Chen, Weisan; Maraskovsky, Eugene; Cebon, Jonathan S |
| 17 | 13-Jul-2012 | Prognostic ability of 18F-FDG PET/CT in the assessment of colorectal liver metastases. | Muralidharan, Vijayaragavan ; Kwok, Marco; Lee, Sze Ting ; Lau, Lawrence F ; Scott, Andrew M ; Christophi, Christopher |
| 18 | 1-Nov-2018 | The prognostic impact of Consensus Molecular Subtypes (CMS) and its predictive effects for bevacizumab benefit in metastatic colorectal cancer: molecular analysis of the AGITG MAX clinical trial. | Mooi, Jennifer K ; Wirapati, P; Asher, R; Lee, C K; Savas, P S; Price, T J; Townsend, A; Hardingham, J; Buchanan, D; Williams, D ; Tejpar, S; Mariadason, John M ; Tebbutt, Niall C |
| 19 | Mar-2021 | Prognostic indices in diffuse large B-cell lymphoma in the rituximab era: an analysis of the UK National Cancer Research Institute R-CHOP 14 versus 21 phase 3 trial. | Gleeson, Mary; Counsell, Nicholas; Cunningham, David; Lawrie, Anthony; Clifton-Hadley, Laura; Hawkes, Eliza A ; McMillan, Andrew; Ardeshna, Kirit M; Burton, Cathy; Chadwick, Nick; Gambell, Joanna; Smith, Paul; Mouncey, Paul; Pocock, Christopher; Radford, John; Davies, John; Turner, Deborah; Kruger, Anton; Johnson, Peter; Linch, David |
| 20 | 30-Oct-2023 | Prognostic Markers within the Tumour Microenvironment in Classical Hodgkin Lymphoma. | Martynchyk, Arina; Chowdhury, Rakin; Hawkes, Eliza A ; Keane, Colm |
